M RE3 Pill - purple round
Pill with imprint M RE3 is Purple, Round and has been identified as Ropinirole Hydrochloride Extended-Release 3 mg. It is supplied by Mylan Pharmaceuticals Inc.
Ropinirole is used in the treatment of Restless Legs Syndrome; Periodic Limb Movement Disorder; Parkinson's Disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 3 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M RE3
Ropinirole Hydrochloride Extended-Release
- Imprint
- M RE3
- Strength
- 3 mg
- Color
- Purple
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-4095
- Inactive Ingredients
-
lactose anhydrous,
ferrosoferric oxide,
silicon dioxide,
ethylcellulose,
FD&C Red No. 40,
FD&C Yellow No. 6,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
propylene glycol,
FD&C Blue No. 2
Note: Inactive ingredients may vary.
Related images for "M RE3"
More about ropinirole
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (326)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: dopaminergic antiparkinsonism agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
